Cloudflare Stock Slides After Massive Outage Impacts Global Services
Cloudflare stock dropped after a widespread outage caused errors across major services like ChatGPT and X.
BTC$60,315.00+1.71%
ETH$1,582.14+2.36%
USDT$0.9985+0.00%
USDC$0.9997+0.01%
XRP$1.06+2.94%
SOL$71.86+4.55%
TRX$0.3207-0.34%
FIGR_HELOC$1.03-0.47%
HYPE$63.17+1.77%
DOGE$0.0752+2.10%
USDS$0.9998+0.03%
RAIN$0.0156-0.32%
LEO$9.37+1.97%
ZEC$409.14+3.45%
XMR$317.57+3.46%
BTC$60,315.00+1.71%
ETH$1,582.14+2.36%
USDT$0.9985+0.00%
USDC$0.9997+0.01%
XRP$1.06+2.94%
SOL$71.86+4.55%
TRX$0.3207-0.34%
FIGR_HELOC$1.03-0.47%
HYPE$63.17+1.77%
DOGE$0.0752+2.10%
USDS$0.9998+0.03%
RAIN$0.0156-0.32%
LEO$9.37+1.97%
ZEC$409.14+3.45%
XMR$317.57+3.46%
Constellation Energy rose more than 3.5% premarket after receiving a $1 billion federal loan to restart the Three Mile Island reactor.
Cloudflare stock dropped after a widespread outage caused errors across major services like ChatGPT and X.
With fresh tax relief and accelerating AI breakthroughs, select U.S. biotechs are entering a rare period of asymmetric upside.
Axalta shares jumped 13% pre-market after announcing an all-stock merger with Akzo Nobel, forming a $25 billion coatings company with $600 million in expected annual synergies.
QUBT gained over 13% after reporting 280% revenue growth to $384,000, turning profitable, and unveiling its new Neurawave photonics platform backed by $1.5 billion in funding.
Dell Technologies fell over 5% in premarket trading after Morgan Stanley downgraded the stock to Underweight, warning that rising memory costs will pressure margins.
Berkshire Hathaway's surprise $4.9 billion stake in Alphabet sent shares soaring 5.5% in premarket trading, representing one of Warren Buffett's final major investment moves before his…
Gold may be absorbing inflation anxiety in 2025, but Bitcoin’s deterministic and decentralized scarcity positions it as the inevitable successor once volatility recalibrates.
Ondas shares jumped nearly 20% after reporting record Q3 revenue of $10.1 million and a 17.7% reduction in net loss.
Anavex stock plunged 50% in premarket trading after European regulators issued a negative vote on its Alzheimer’s drug blarcamesine.
Tesla shares dipped in premarket after the company recalled 10,500 Powerwall 2 units over overheating issues tied to faulty battery cells.
Bitfarms slid 13% after missing Q3 EPS and revenue targets and announcing a shift toward AI infrastructure at its Washington site.
Mersana stock soared 200% premarket after Day One Biopharma agreed to buy the company for $25 per share plus potential milestone payments.